Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial

H Zeitler1, Y Ko, C Zimmermann

  • 1Medizinische Universitäts-Poliklinik, Willhelmstr. 35-37, Bonn D-53111, Germany.

Insights

Elevated soluble adhesion molecules (SAMs) are linked to coronary heart disease and acute myocardial infarction. High SAM levels may predict fatal outcomes in heart attack patients, independent of other risk factors.

Area of Science:

  • Cardiovascular research
  • Immunology
  • Biomarker discovery

Background:

  • Adhesion molecules are crucial in chronic conditions, including atherosclerosis.
  • Soluble adhesion molecules (SAMs) are implicated in angiogenesis, a key process in atherosclerosis.
  • Assessing SAMs in atherosclerosis provides insights into disease mechanisms.

Purpose of the Study:

  • To determine the prevalence of elevated soluble adhesion molecule plasma concentrations in patients with atherosclerosis.
  • To investigate the impact of these elevated levels on cardiovascular disease outcomes.
  • To explore the role of SAMs in the acute and chronic phases of atherosclerosis.

Main Methods:

  • Measured plasma concentrations of soluble intercellular adhesive molecule (sICAM), soluble endothelial adhesive molecule (sELAM), and soluble vascular adhesive molecule (sVCAM).
  • Utilized a sandwich ELISA technique for precise quantification.
  • Compared levels in patients with acute myocardial infarction (AMI), coronary heart disease (CHD), and healthy subjects (HS).

Main Results:

  • Patients with CHD and AMI exhibited significantly higher plasma levels of sICAM, sELAM, and sVCAM compared to healthy subjects.
  • Elevated SAM levels were observed in patients with fatal myocardial infarction outcomes versus survivors.
  • SAM levels were not correlated with common cardiovascular risk factors such as diabetes or hypertension.

Conclusions:

  • Elevated SAM levels are prevalent in patients with coronary heart disease.
  • High plasma SAM concentrations serve as a prognostic indicator for acute myocardial infarction, independent of other risk factors.
  • SAMs appear to play a role in both the acute inflammatory response of myocardial infarction and the chronic progression of atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...